Inkeun Park

Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

Michiel S. van der Heijden, Matthew D. Galsky, Yohann Loriot et al. · The Lancet Oncology · 2020 · 498 citations · Full text

Medicine, Oncology, Pharmacology +14

Prognostic Significance of CT-Determined Sarcopenia in Patients with Small-Cell Lung Cancer

Eun Young Kim, Young Saing Kim, Inkeun Park et al. · Journal of Thoracic Oncology · 2015 · 249 citations · Full text

Medicine, Oncology, Radiology +16

RandomizEd phase II trial of Sunitinib four weeks on and two weeks off versus Two weeks on and One week off in metastatic clear-cell type REnal cell carcinoma: RESTORE trial

J.L. Lee, M.K. Kim, Inkeun Park et al. · Annals of Oncology · 2015 · 108 citations

Medicine, Oncology, Pharmacotherapy +10

The Relationship between Sarcopenia and Systemic Inflammatory Response for Cancer Cachexia in Small Cell Lung Cancer

Eun Young Kim, Young Saing Kim, Ja-Young Seo et al. · PLoS ONE · 2016 · 106 citations · Full text

Medicine, Oncology, Radiology +14

Prognostic factors and predictive model in patients with advanced biliary tract adenocarcinoma receiving first‐line palliative chemotherapy

Inkeun Park, Jae‐Lyun Lee, Min‐Hee Ryu et al. · Cancer · 2009 · 74 citations · Full text

Medicine, Oncology, Surgery +15